Publications

  1. Park WD, Kim DY, Mai ML, Reddy KS, Gonwa T, Ryan MS, Herrera Hernandez LP, Smith ML, Geiger XJ, Turkevi-Nagy S, Cornell LD, Smith BH, Kremers WK, Stegall MD. Progressive decline of function in renal allografts with normal 1-year biopsies: Gene expression studies fail to identify a classifier. Clin Transplant. 2021 Dec; 35 (12):e14456 Epub 2021 Nov 09
    View PubMed
  2. Keller CA, Gonwa TA, White LJ, Rucci ME, Visscher SL, Kennedy CC, Daly RC, Naessens JM. Utilization and Cost Analysis of Lung Transplantation and Survival After 10 Years of Adapting the Lung Allocation Score. Transplantation. 2019 Mar; 103 (3):638-646
    View PubMed
  3. Keller CA, Gonwa TA, Russell AL, Hodge DO, Erasmus DB, Zubair AC. Preliminary Report on the Effect of Mesenchymal Stem Cell Therapy in Patients With Chronic Allograft Dysfunction Stem Cells Transl Med. 2018.
  4. Keller CA, Gonwa TA, Hodge DO, Hei DJ, Centanni JM, Zubair AC. Feasibility, Safety, and Tolerance of Mesenchymal Stem Cell Therapy for Obstructive Chronic Lung Allograft Dysfunction. Stem Cells Transl Med. 2018 Feb; 7 (2):161-167 Epub 2018 Jan 11
    View PubMed
  5. Saucedo-Crespo H, Haakinson DJ, Croome KP, Mai ML, Taner CB, Heilman RL, Gonwa T. Prognostic factors in kidney transplantation in the septuagenarian: a multicenter analysis. Clin Transplant. 2016 Jul; 30 (7):828-35 Epub 2016 June 09
    View PubMed
  6. Saull HE, Enderby CY, Gonwa TA, Wadei HM. Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non-sensitized renal transplant patients treated with rapid steroid withdrawal. Clin Transplant. 2015 Jul; 29 (7):573-80 Epub 2015 Mar 24
    View PubMed
  7. Wadei HM, Heckman MG, Rawal B, Taner CB, Mai ML, Cortese C, Rosser BG, Gonwa TA, Keaveny AP. Renal outcomes of liver transplant recipients who had pretransplant kidney biopsy. Transplantation. 2014 Dec 27; 98(12):1323-30.
    View PubMed
  8. Wadei HM, Bulatao IG, Gonwa TA, Mai ML, Prendergast M, Keaveny AP, Rosser BG, Taner CB. Inferior long-term outcomes of liver-kidney transplantation using donation after cardiac death donors: single-center and organ procurement and transplantation network analyses. Liver Transpl. 2014 Jun; 20(6):728-35.
    View PubMed
  9. Gonwa TA. Should MARS and Prometheus be used in patients with liver disease? Semin Dial. 2014 May-Jun; 27(3):228-31. Epub 2014 Mar 06.
    View PubMed
  10. Gonwa TA, Wadei HM. Kidney disease in the setting of liver failure: core curriculum 2013. Am J Kidney Dis. 2013 Dec; 62(6):1198-212. Epub 2013 Oct 04.
    View PubMed
  11. Chakkera HA, Chang YH, Ayub A, Gonwa TA, Weil EJ, Knowler WC. Validation of a pretransplant risk score for new-onset diabetes after kidney transplantation. Diabetes Care. 2013 Oct; 36(10):2881-6. Epub 2013 Sep 05.
    View PubMed
  12. Wadei HM, Heckman MG, Rawal B, Taner CB, Farahat W, Nur L, Mai ML, Prendergast M, Gonwa TA. Comparison of kidney function between donation after cardiac death and donation after brain death kidney transplantation. Transplantation. 2013 Aug 15; 96(3):274-81.
    View PubMed
  13. Mai ML, Mai WK, Taner CB, Prendergast MB, Wadei HM, Gonwa TA. Antithymocyte globulin induction and rapid steroid taper leads to excellent results in kidney transplantation with donation after cardiac death donors: importance of rejection and delayed graft function. Transplant Proc. 2013 May; 45(4):1528-30.
    View PubMed
  14. Katsolis JG, Bosch W, Heckman MG, Diehl NN, Shalev JA, Pungpapong S, Gonwa TA, Hellinger WC. Evaluation of risk factors for cytomegalovirus infection and disease occurring within 1 year of liver transplantation in high-risk patients. Transpl Infect Dis. 2013 Apr; 15(2):171-80. Epub 2013 Jan 18.
    View PubMed
  15. Wadei HM, Gonwa TA. Hepatorenal syndrome in the intensive care unit. J Intensive Care Med. 2013 Mar-Apr; 28 (2):79-92 Epub 2011 Aug 21
    View PubMed
  16. Bosch W, Poowanawittayakom N, Chaikriangkrai K, Mendez J, Hellinger WC, Gonwa TA, Krishna M, Pungpapong S. Tuberculous hepatitis in renal transplant recipients following alemtuzumab induction therapy. Transpl Infect Dis. 2013 Feb; 15 (1):E33-9 Epub 2012 Dec 26
    View PubMed
  17. Leaphart CL, Gonwa TA, Mai ML, Prendergast MB, Wadei HM, Tepas JJ 3rd, Taner CB. Formal quality improvement curriculum and DMAIC method results in interdisciplinary collaboration and process improvement in renal transplant patients. J Surg Res. 2012 Sep; 177(1):7-13. Epub 2012 Mar 30.
    View PubMed
  18. Wadei HM, Zaky ZS, Keaveny AP, Rosser B, Jones M, Mai ML, Bulatao I, Gonwa TA. Proteinuria following sirolimus conversion is associated with deterioration of kidney function in liver transplant recipients. Transplantation. 2012 May 27; 93(10):1006-12.
    View PubMed
  19. Heilman RL, Cortese C, Geiger XJ, Younan K, Wadei HM, Mai ML, Reddy KS, Gonwa TA. Impact of early conversion from tacrolimus to sirolimus on chronic allograft changes in kidney recipients on rapid steroid withdrawal. Transplantation. 2012 Jan 15; 93 (1):47-53
    View PubMed
  20. Gonwa TA, Wadei HM. The challenges of providing renal replacement therapy in decompensated liver cirrhosis. Blood Purif. 2012; 33 (1-3):144-8 Epub 2012 Jan 20
    View PubMed
  21. Heilman RL, Younan K, Wadei HM, Mai ML, Reddy KS, Chakkera HA, Gonwa TA. Results of a prospective randomized trial of sirolimus conversion in kidney transplant recipients on early corticosteroid withdrawal. Transplantation. 2011 Oct 15; 92 (7):767-73
    View PubMed
  22. Gonwa TA, McBride MA, Mai ML, Wadei HM. Kidney transplantation after previous liver transplantation: analysis of the organ procurement transplant network database. Transplantation. 2011 Jul 15; 92 (1):31-5
    View PubMed
  23. Mai ML, Wadei H, Gonwa TA. Rabbit anti-thymocyte globulin: Evidence for clinical benefit in high immunological risk kidney transplantation. Clinical Medicine Insights: Therapeutics. 2011; 3:39-49.
  24. Gonwa TA. Hepatorenal syndrome and liver transplantation. Front Gastrointest Res. 2011; 28:198-207.
  25. Panjala C, Kodali L, Harnois DM, Wadei HM, Mai ML, Gonwa TA, Ahsan N. Impact of iothalamate clearance generated serum creatinine on MELD score and organ allocation in liver transplant recipients. Am J Transplant. 2010 Apr; 10(Sp Iss SI Suppl 4):357-8.
  26. Charlton MR, Wall WJ, Ojo AO, Gines P, Textor S, Shihab FS, Marotta P, Cantarovich M, Eason JD, Wiesner RH, Ramsay MA, Garcia-Valdecasas JC, Neuberger JM, Feng S, Davis CL, Gonwa TA, International Liver Transplantation Society Expert Panel. Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. Liver Transpl 2009 Nov; 15 (11):S1-34
    View PubMed
  27. Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin. Transplantation. 2009 Jan 27; 87(2):227-32.
    View PubMed
  28. Chakkera HA, Chertow GM, O'Hare AM, Amend WJ Jr, Gonwa TA. Regional variation in kidney transplant outcomes: trends over time. Clin J Am Soc Nephrol. 2009 Jan; 4 (1):152-9 Epub 2008 Oct 15
    View PubMed
  29. Wadei HM, Geiger XJ, Cortese C, Mai ML, Kramer DJ, Rosser BG, Keaveny AP, Willingham DL, Ahsan N, Gonwa TA. Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsy. Am J Transplant. 2008 Dec; 8 (12):2618-26
    View PubMed
  30. Eason JD, Gonwa TA, Davis CL, Sung RS, Gerber D, Bloom RD. Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK). Am J Transplant. 2008 Nov; 8(11):2243-51. Epub 2008 Sep 19.
    View PubMed
  31. Wadei HM, Brumble L, Broderick GA, Gonwa TA. Polymicrobial seminal vesical abscess in a kidney transplant recipient. Urology. 2008 Aug; 72: (2)296.
    View PubMed
  32. Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am J Transplant. 2006 Nov; 6 (11):2651-9 Epub 2006 Aug 25
    View PubMed
  33. Mai ML, Ahsan N, Gonwa T. The long-term management of pancreas transplantation. Transplantation. 2006 Oct 27; 82(8):991-1003.
    View PubMed
  34. Wadei HM, Mai ML, Ahsan N, Gonwa TA. Hepatorenal syndrome: Pathophysiology and management. Clin J Am Soc Nephrol. 2006 Sep; 1(5):1066-79.
  35. Wadei HM, Mai ML, Ahsan N, Gonwa TA. Hepatorenal syndrome: pathophysiology and management. Clin J Am Soc Nephrol. 2006 Sep; 1 (5):1066-79 Epub 2006 July 12
    View PubMed
  36. Mendez R, Gonwa T, Yang HC, Weinstein S, Jensik S, Steinberg S. A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: Results at 1 year. Transplantation. 2005 Aug 15; 80(3):303-9.
    View PubMed
  37. Sanchez EQ, Gonwa TA, Levy MF, Goldstein RM, Mai ML, Hays SR, Melton LB, Saracino G, Klintmalm GB. Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation. 2004 Oct 15; 78(7):1048-54.
    View PubMed
  38. Mai ML, Gonwa TA. Renal dysfunction and orthotopic liver transplantation: management strategies and indications for combined liver and kidney transplantation. Curr Opin Organ Transplant. 2004 Jun; 9(2):116-22.
  39. Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl. 2004 Feb; 10 (2):301-9
    View PubMed
  40. Kahan BD, Karlix JL, Ferguson RM, Leichtman AB, Mulgaonkar S, Gonwa TA, Skerjanec A, Schmouder RL, Chodoff L. Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: A multicenter, randomized, placebo-controlled, phase I study. Transplantation. 2003 Oct 15; 76(7):1079-84.
    View PubMed
  41. Gonwa TA. Treatment of renal dysfunction after orthotopic liver transplantation: Options and outcomes. Liver Transpl. 2003 Jul; 9(7):778-9.
    View PubMed
  42. Gonwa T, Johnson C, Ahsan N, Alfrey EJ, Halloran P, Stegall M, Hardy M, Metzger R, Shield C 3rd, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, VanVeldhuisen P, Leonhardt M, Fitzsimmons WE. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years. Transplantation. 2003 Jun 27; 75 (12):2048-53
    View PubMed
  43. Gonwa T, Mendez R, Yang HC, Weinstein S, Jensik S, Steinberg S, Prograf Study Group. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months. Transplantation. 2003 Apr 27; 75: (8)1213-20.
    View PubMed
  44. Vats A, Shapiro R, Singh Randhawa P, Scantlebury V, Tuzuner A, Saxena M, Moritz ML, Beattie TJ, Gonwa T, Green MD, Ellis D. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation. 2003 Jan 15; 75(1):105-12.
    View PubMed
  45. Gonwa TA, Hricik DE, Brinker K, Grinyo JM, Schena FP. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination. Transplantation. 2002 Dec 15; 74(11):1560-7.
    View PubMed
  46. Molmenti EP, Netto GJ, Murray NG, Smith DM, Molmenti H, Crippin JS, Hoover TC, Jung G, Marubashi S, Sanchez EQ, Gogel B, Levy MF, Goldstein RM, Fasola CG, Gonwa TA, Klintmalm GB. Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. Liver Transpl. 2002 Jun;8(6):519-26.
    View PubMed
  47. Gonwa TA, Mai ML, Melton LB, Smith D, Levy MF, Goldstein RM, Klintmalam GB. Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: use of low dose tacrolimus therapy with post-operative administration of anti-CD25 monoclonal antibody. Clin Transplant. 2002 Apr; 16(2):144-9.
    View PubMed
  48. Davis CL, Gonwa TA, Wilkinson AH. Identification of patients best suited for combined liver-kidney transplantation: Part II. Liver Transpl. 2002 Mar; 8(3):193-211.
    View PubMed
  49. Sanchez EQ, Marubashi S, Jung G, Levy MF, Goldstein RM, Molmenti EP, Fasola CG, Gonwa TA, Jennings LW, Brooks BK, Klintmalm GB. De novo tumors after liver transplantation: a single-institution experience. Liver Transpl. 2002 Mar;8(3):285-91.
    View PubMed
  50. Davis CL, Gonwa TA, Wilkinson AH. Pathophysiology of renal disease associated with liver disorders: Implications for liver transplantation. Part I. Liver Transpl. 2002 Feb; 8(2):91-109.
    View PubMed
  51. Molmenti EP, Levy MF, Molmenti H, Casey D, Fasola CG, Hamilton WM, Jung G, Marubashi S, Gogel BM, Goldstein RM, Gonwa TA, Klintmalm GB. Correlation between intraoperative blood flows and hepatic artery strictures in liver transplantation. Liver Transpl. 2002 Feb;8(2):160-3.
    View PubMed
  52. Molmenti EP, Roodhouse TW, Molmenti H, Jaiswal K, Jung G, Marubashi S, Sanchez EQ, Gogel B, Levy MF, Goldstein RM, Fasola CG, Elliott EE, Bursac N, Mulligan D, Gonwa TA, Klintmalm GB. Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Ann Surg. 2002 Feb;235(2):292-6.
    View PubMed
  53. Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF, Klintmalm GB. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment. Transplantation. 2001 Dec 27; 72(12):1934-9.
    View PubMed
  54. Gonwa TA. Hypertension and renal dysfunction in long-term liver transplant recipients. Liver Transpl. 2001 Nov; 7 (11 Suppl 1):S22-6
    View PubMed
  55. Molmenti EP, Molmenti H, Marubashi S, Sanchez EQ, Gogel B, Goldstein RM, Levy MF, Fasola CG, Gonwa TA, Klintmalm GB. Cannulation of the aorta in organ donors with aortic and caval injuries at the time of procurement. Pediatr Transplant. 2001 Oct; 5(5):378-80.
    View PubMed
  56. Ahsan N, Johnson C, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C 3rd, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, VanVeldhuisen P, Salm K, Tolzman D, Fitzsimmons WE. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years. Transplantation. 2001 Jul 27; 72(2):245-50.
    View PubMed
  57. Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF, Klintmalm GB. Renal replacement therapy and orthotopic liver transplantation: the role of continuous veno-venous hemodialysis. Transplantation. 2001 May 27; 71(10):1424-8.
    View PubMed
  58. Molmenti E, Casey D, Jennings L, Molmenti H, Jung G, Marubashi S, Sanchez E, Goldstein R, Levy M, Fasola C, Gonwa T, Klintmalm G. Leading causes of death in the liver transplant population compared to the corresponding age-matched general US population. Transplant Proc. 2001 Feb-Mar; 33(1-2):1531.
    View PubMed
  59. Molmenti EP, Casey D, Coke C, Jennings L, Brooks B, Marubashi S, Molmenti H, Goldstein R, Levy M, Fasola C, Gonwa T, Klintmalm G. Correlation between intraoperative flows and hepatic artery strictures in liver transplantation. Transplant Proc. 2001 Feb-Mar; 33(1-2):1494.
    View PubMed
  60. Levy MF, Greene L, Ramsay MA, Jennings LW, Ramsay KJ, Meng J, Hein HA, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB. Readmission to the intensive care unit after liver transplantation. Crit Care Med. 2001 Jan; 29(1):18-24.
    View PubMed
  61. Levy MF, Somasundar PS, Jennings LW, Jung GJ, Molmenti EP, Fasola CG, Goldstein RM, Gonwa TA, Klintmalm GB. The elderly liver transplant recipient: a call for caution. Ann Surg. 2001 Jan; 233(1):107-13.
    View PubMed
  62. Testa G, Crippin JS, Netto GJ, Goldstein RM, Jennings LW, Brkic BS, Brooks BK, Levy MF, Gonwa TA, Klintmalm GB. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients. Liver Transpl. 2000 Sep; 6(5):553-61.
    View PubMed
  63. Pescovitz MD, Conti D, Dunn J, Gonwa T, Halloran P, Sollinger H, Tomlanovich S, Weinstein S, Inokuchi S, Kiberd B, Kittur D, Merion RM, Norman D, Shoker A, Wilburn R, Nicholls AJ, Arterburn S, Dumont E. Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics. Clin Transplant. 2000 Jun; 14(3):179-88.
    View PubMed
  64. Gonwa TA. Transplantation. Am J Kidney Dis. 2000 Apr; 35(4 Suppl 1):S153-9.
    View PubMed
  65. Johnson C, Ahsan N, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C 3rd, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, van Veldhuisen P, Salm K, Tolzman D, Fitzsimmons WE. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. Transplantation. 2000 Mar 15; 69(5):834-41.
    View PubMed
  66. Levy MF, Crippin J, Sutton S, Netto G, McCormack J, Curiel T, Goldstein RM, Newman JT, Gonwa TA, Banchereau J, Diamond LE, Byrne G, Logan J, Klintmalm GB. Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus. Transplantation. 2000 Jan 27; 69(2):272-80.
    View PubMed
  67. Gerhardt TC, Levy MF, Jennings L, Abbasoglu O, Testa G, Jeyarajah R, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB. Comparing quality of life following liver transplantation for Laennec's vs non-Laennec's patients. Clin Transplant. 2000; 14:115-20.
    View PubMed
  68. Gonwa TA. Immunosuppressive drugs. Dallas Medical Journal. 2000; 86:72-3.
  69. Jeyarajah DR, Netto GJ, Lee SP, Testa G, Abbasoglu O, Husberg BS, Levy MF, Goldstein RM, Gonwa TA, Tillery GW, Crippin JS, Klintmalm GB. Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process? Transplantation. 1998 Nov 27; 66(10):1300-6.
    View PubMed
  70. Pescovitz MD, Pruett TL, Gonwa T, Brook B, McGory R, Wicker K, Griffy K, Robinson CA, Jung D. Oral ganciclovir dosing in transplant recipients and dialysis patients based on renal function. Transplantation. 1998 Oct 27; 66(8):1104-7.
    View PubMed
  71. Abbasoglu O, Levy MF, Testa G, Obiekwe S, Brkic BS, Jennings LW, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB. Does intraoperative hepatic artery flow predict arterial complications after liver transplantation? Transplantation. 1998 Sep 15; 66(5):598-601.
    View PubMed
  72. Fabia R, Levy MF, Testa G, Obiekwe S, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB. Colon carcinoma in patients undergoing liver transplantation. Am J Surg. 1998 Sep; 176(3):265-9.
    View PubMed
  73. Jeyarajah DR, Gonwa TA, Testa G, Abbasoglu O, Goldstein R, Husberg BS, Levy MF, Klintmalm GB. Liver and kidney transplantation for polycystic disease. Transplantation. 1998 Aug 27; 66(4):529-32.
    View PubMed
  74. Testa G, Goldstein RM, Netto G, Abbasoglu O, Brooks BK, Levy MF, Husberg BS, Gonwa TA, Klintmalm GB. Long-term outcome of patients transplanted with livers from hepatitis C-positive donors. Transplantation. 1998 Apr 15; 65(7):925-9.
    View PubMed
  75. Prabhakar G, Testa G, Abbasoglu O, Jeyarajah DR, Goldstein RM, Levy MF, Husberg BS, Gonwa TA, Klintmalm GB. The safety of cardiac operations in the liver transplant recipient. Ann Thorac Surg. 1998 Apr; 65(4):1060-4.
    View PubMed
  76. Testa G, Goldstein RM, Toughanipour A, Abbasoglu O, Jeyarajah R, Levy MF, Husberg BS, Gonwa TA, Klintmalm GB. Guidelines for surgical procedures after liver transplantation. Ann Surg. 1998 Apr; 227(4):590-9.
    View PubMed
  77. Fabia R, Levy MF, Crippin J, Tillery W, Netto GJ, Aguanno J, Dysert P, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB. De novo hepatitis B infection after liver transplantation: source of disease, incidence, and impact. Liver Transpl Surg. 1998 Mar; 4(2):119-27.
    View PubMed
  78. Jeyarajah DR, Gonwa TA, McBride M, Testa G, Abbasoglu O, Husberg BS, Levy MF, Goldstein RM, Klintmalm GB. Hepatorenal syndrome: combined liver kidney transplants versus isolated liver transplant. Transplantation. 1997 Dec 27; 64(12):1760-5.
    View PubMed
  79. Abbasoglu O, Levy MF, Brkic BB, Testa G, Jeyarajah DR, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB. Ten years of liver transplantation: an evolving understanding of late graft loss. Transplantation. 1997 Dec 27; 64(12):1801-7.
    View PubMed
  80. Jeyarajah DR, McBride M, Klintmalm GB, Gonwa TA. Combined liver-kidney transplantation: what are the indications? Transplantation. 1997 Oct 27; 64(8):1091-6.
    View PubMed
  81. Brooks BK, Levy MF, Jennings LW, Abbasoglu O, Vodapally M, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB. Influence of donor and recipient gender on the outcome of liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):475-6.
    View PubMed
  82. Neylan J, de Smet W, Stijlemans B, Brinker K, Gonwa T, Moran J, Segers A. Detection of clinically relevant antibodies pretransplant and posttransplant with PRA-STAT. The Anti-CD45 Study Group. Transplant Proc. 1997 Feb-Mar; 29(1-2):330-2.
    View PubMed
  83. Abbasoglu O, Levy MF, Vodapally MS, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB. Hepatic artery stenosis after liver transplantation--incidence, presentation, treatment, and long term outcome. Transplantation. 1997 Jan 27; 63(2):250-5.
    View PubMed
  84. Brooks BK, Levy MF, Jennings LW, Abbasoglu O, Vodapally M, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB. Influence of donor and recipient gender on the outcome of liver transplantation. Transplantation. 1996 Dec 27;62(12):1784-7.
    View PubMed
  85. Gerhardt TC, Goldstein RM, Urschel HC, Tripp LE, Levy MF, Husberg BS, Jennings LW, Gonwa TA, Klintmalm GB. Alcohol use following liver transplantation for alcoholic cirrhosis. Transplantation. 1996 Oct 27; 62(8):1060-3.
    View PubMed
  86. Levy MF, Crippin JS, Abbasoglu O, Vodapally M, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB. Adenovirus infection of the human intestinal allograft: a case report. Transplant Proc. 1996 Oct; 28(5):2786-7.
    View PubMed
  87. Gonwa TA. Mycophenolate mofetil for maintenance therapy in kidney transplantation. Clin Transplant. 1996 Feb; 10(1 Pt 2):128-30.
    View PubMed
  88. Plevack DJ, Gonwa TA, Kelley SD, Scott VL, Park JR. Forum on critical care issues in liver transplantation: fluids, electrolytes, and renal disease in the perioperative liver transplant recipient. Liver Transpl Surg. 1996; 2:69-86.
  89. Gonwa TA. Mycophenolate mofetil for prevention of rejection in kidney transplant recipients. Transplantation and Immunology Letter. 1996; 12(2):4-6.
  90. Hasse JM, Blue LS, Liepa GU, Goldstein RM, Jennings LW, Mor E, Husberg BS, Levy MF, Gonwa TA, Klintmalm GB. Early enteral nutrition support in patients undergoing liver transplantation. JPEN: Journal of Parenteral & Enteral Nutrition. 1995 Nov-Dec; 19(6):437-43.
    View PubMed
  91. Klintmalm GB, Gonwa TA. Nephrotoxicity associated with cyclosporine and FK506. Liver Transpl Surg. 1995 Sep; 1(5 Suppl 1):11-9.
    View PubMed
  92. Levy MF, Jennings L, Abouljoud MS, Mulligan DC, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB. Quality of life improvements at one, two, and five years after liver transplantation. Transplantation. 1995 Feb 27; 59(4):515-8.
    View PubMed
  93. Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS. Impact of pretransplant renal function on survival after liver transplantation. Transplantation. 1995 Feb 15; 59(3):361-5.
    View PubMed
  94. Porayko MK, Gonwa TA, Klintmalm GB, Wiesner RH. Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group. Transplant Proc. 1995 Feb; 27(1):1114-6.
    View PubMed
  95. Mulligan DC, Goldstein RM, Crippin JS, Abouljoud MS, Levy MF, Husberg BS, Gonwa TA, Foster BR, Tillery GW, Klintmalm GB. Use of anti-hepatitis C virus seropositive organs in liver transplantation. Transplant Proc. 1995 Feb; 27(1):1204-5.
    View PubMed
  96. Nikaein A, Backman L, Jennings L, Levy M, Goldstein R, Gonwa T, Stone M, Klintmalm G. HLA compatibility and liver transplant outcome: improved patient survival by HLA and crossmatching. Transplant Proc. 1995 Feb; 27(1):1186-8.
    View PubMed
  97. Abouljoud MS, Levy MF, Rees CR, Diamond NG, Lee SP, Mulligan DC, Goldstein RM, Husberg B, Gonwa TA, Klintmalm GB. A comparison of treatment with transjugular intrahepatic portosystemic shunt or distal splenorenal shunt in the management of variceal bleeding prior to liver transplantation. Transplantation. 1995 Jan 27; 59(2):226-9.
    View PubMed
  98. Solinger HW, The US Renal Mycophenolate Mofetil Study Group. Mycophenolate Mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation. 1995; 60:225-32.
  99. Nikaein A, Backman L, Jennings L, Levy MF, Goldstein R, Gonwa T, Stone MJ, Klintmalm G. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching. Transplantation. 1994 Oct 15; 58(7):786-92.
    View PubMed
  100. Backman L, Nicar M, Levy M, Distant D, Eisenstein C, Renard T, Goldstein R, Husberg B, Gonwa T, Klintmalm G. Whole blood and plasma levels of FK 506 after liver transplantation: correlation with toxicity. Transplant Proc. 1994 Jun; 26(3):1804.
    View PubMed
  101. Backman L, Nicar M, Levy M, Distant D, Eisenstein C, Renard T, Goldstein R, Husberg B, Gonwa TA, Klintmalm G. FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects. Transplantation. 1994 Feb 27; 57(4):519-25.
    View PubMed
  102. Gonwa TA. Kidney transplantation; new insights into chronic rejection. New Developments in Transplantation Medicine. 1994; 1:8-9.
  103. Goldstein RM, Stone M, Tillery GW, Senzer N, Levy M, Husberg BS, Gonwa T, Klintmalm G. Is liver transplantation indicated for cholangiocarcinoma? Am J Surg. 1993 Dec; 166(6):768-71; discussion 771-2.
    View PubMed
  104. Distant DA, Gonwa TA. The kidney in liver transplantation. J Am Soc Nephrol. 1993 Aug; 4(2):129-36.
    View PubMed
  105. Gonwa TA, Atkins C, Zhang YA, Parker TF, Hunt JM, Lu CY, White MG. Glomerular filtration rates in persons evaluated as living-related donors--are our standards too high? Transplantation. 1993 May; 55(5):983-5.
    View PubMed
  106. Backman L, Gibbs J, Levy M, McMillan R, Holman M, Husberg B, Goldstein R, Gonwa TA, Klintmalm G. Causes of late graft loss after liver transplantation. Transplantation. 1993 May; 55(5):1078-82.
    View PubMed
  107. Klintmalm GB, Gibbs JF, McMillan R, Backman L, Levy M, Goldstein RM, Husberg BS, Holman MJ, Gonwa TA. Rejection: FK 506 for rescue or maintenance. Transplant Proc. 1993 Apr; 25(2):1914-5.
    View PubMed
  108. Gonwa TA, Goldstein M, Holman M, Husberg BS, Klintmalm GB. Orthotopic liver transplantation and renal function; outcome of hepatorenal syndrome and trial of verapamil for renal protection in nonhepatorenal syndrome. Transplant Proc. 1993 Apr; 25(2):1891-2.
    View PubMed
  109. Mor E, Jennings L, Gonwa TA, Holman MJ, Gibbs J, Solomon H, Goldstein RM, Husberg BS, Watemberg IA, Klintmalm GB. The impact of operative bleeding on outcome in transplantation of the liver. Surgery, Gynecology & Obstetrics. 1993 Mar; 176(3):219-27.
    View PubMed
  110. Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW Jr, Stratta R, Ascher NL, Roberts JW, Lake J. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. Transplant Proc. 1993 Feb; 25(1 Pt 1):641-3.
    View PubMed
  111. Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW Jr, Stratta R, Ascher NL, Roberts JW, Lake J. Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. Transplant Proc. 1993 Feb; 25(1 Pt 1):679-88.
    View PubMed
  112. Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW Jr, Stratta R, Ascher NL, Roberts JW, Lake J. Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group. Transplant Proc. 1993 Feb; 25(1 Pt 1):635-7.
    View PubMed
  113. Klintmalm GB, Ascher NL, Busuttil RW, Deierhoi M, Gonwa TA, Kauffman R, McDiarmid S, Poplawski S, Sollinger H, Roberts J. RS-61443 for treatment-resistant human liver rejection. Transplant Proc. 1993 Feb; 25(1 Pt 1):697.
    View PubMed
  114. Sollinger HW, Belzer FO, Deierhoi MH, Diethelm AG, Gonwa TA, Kauffman RS, Klintmalm GB, McDiarmid SV, Roberts J, Rosenthal JT, et al. RS-61443: rescue therapy in refractory kidney transplant rejection. Transplant Proc. 1993 Feb; 25(1 Pt 1):698-9.
    View PubMed
  115. Backman L, Gibbs J, Levy M, McMillan R, Holman M, Husberg B, Goldstein R, Gonwa TA, Klintmalm G. Late graft loss after liver transplantation: a study of 434 consecutive patients. Transplant Proc. 1993 Feb; 25(1 Pt 2):1111-2.
    View PubMed
  116. Stephens J, Goldstein R, Crippin J, Husberg B, Holman M, Gonwa TA, Klintmalm G. Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients. Transplant Proc. 1993 Feb; 25(1 Pt 2):1122-3.
    View PubMed
  117. Goldstein R, Tripp L, Clemmons J, Husberg B, Gonwa TA, Polter D, Klintmalm G. Liver transplantation for alcoholic cirrhosis--do they mix? Transplant Proc. 1993 Feb; 25(1 Pt 2):1131-2.
    View PubMed
  118. Levy M, Backman L, Husberg B, Goldstein R, McMillan R, Gibbs J, Gonwa TA, Holman M, Klintmalm G. De novo malignancy following liver transplantation: a single-center study. Transplant Proc. 1993 Feb; 25(1 Pt 2):1397-9.
    View PubMed
  119. Gibbs JF, Husberg BS, Klintmalm GB, Backman L, Levy M, McMillan R, Goldstein RM, Holman MJ, Gonwa TA, Morris C. Outcome analysis of FK 506 therapy for acute and chronic rejection. Transplant Proc. 1993 Feb; 25(1 Pt 1):622-3.
    View PubMed
  120. Levy MF, Goldstein RM, Husberg BS, Gonwa TA, Backman L, Abouljoud M, Mulligan D, Klintmalm GB. Baylor update: outcome analysis in liver transplantation. Clin Transpl. 1993; 161-73.
  121. Holman MJ, Gonwa TA, Cooper B, Husberg BS, Goldstein RM, Gibbs JF, Klintmalm GB. FK506-associated thrombotic thrombocytopenic purpura. Transplantation. 1993 Jan; 55(1):205-6.
    View PubMed
  122. Solomon H, Gonwa TA, Mor E, Holman MJ, Gibbs J, Watemberg I, Netto G, Goldstein RM, Husberg BS, Klintmalm GB. OKT3 rescue for steroid-resistant rejection in adult liver transplantation. Transplantation. 1993 Jan; 55(1):87-91.
    View PubMed
  123. Mora NP, Gonwa TA, Goldstein RM, Husberg BS, Klintmalm GB. Risk of postoperative infection after liver transplantation: a univariate and stepwise logistic regression analysis of risk factors in 150 consecutive patients. Clin Transplant. 1993; 46:443-9.
  124. Mor E, Gonwa TA, Husberg BS, Goldstein RM, Klintmalm GB. Late-onset acute rejection in orthotopic liver transplantation--associated risk factors and outcome. Transplantation. 1992 Nov; 54(5):821-4.
    View PubMed
  125. Sollinger HW, Belzer FO, Deierhoi MH, Diethelm AG, Gonwa TA, Kauffman RS, Klintmalm GB, McDiarmid SV, Roberts J, Rosenthal JT, et al. RS-61443 (mycophenolate mofetil). A multicenter study for refractory kidney transplant rejection. Ann Surg. 1992 Oct; 216(4):513-8; discussion 518-9.
    View PubMed
  126. Gonwa TA, Mai ML, Pilcher J, Johnson C, Pierson S, Capehart JE, Alivizatos PA. Stability of long-term renal function in heart transplant patients treated with induction therapy and low-dose cyclosporine. J Heart Lung Transplant. 1992 Sep-Oct; 11(5):926-8.
    View PubMed
  127. Jett GK, Miller A, Savino D, Gonwa T. Reversal of acute fulminant lymphocytic myocarditis with combined technology of OKT3 monoclonal antibody and mechanical circulatory support. J Heart Lung Transplant. 1992 Jul-Aug; 11(4 Pt 1):733-8.
    View PubMed
  128. Howard TK, Klintmalm GB, Stone MJ, Cofer JB, Husberg BS, Goldstein RM, Gonwa TA. Lymphoproliferative disorder masquerading as rejection in liver transplant recipients--an early aggressive tumor with atypical presentation. Transplantation. 1992 May; 53(5):1145-7.
    View PubMed
  129. Mora NP, Klintmalm GB, Solomon H, Goldstein RM, Gonwa TA, Husberg BS. Survival after liver transplantation in 300 consecutive patients: the influence of age, clinical status, and pretransplant disease. Transplant Proc. 1992 Feb; 24(1):156-7.
    View PubMed
  130. Mora NP, Klintmalm G, Solomon H, Goldstein RM, Gonwa TA, Husberg BS. Selective amphotericin B prophylaxis in the reduction of fungal infections after liver transplant. Transplant Proc. 1992 Feb; 24(1):154-5.
    View PubMed
  131. Mor E, Klintmalm GB, Gonwa TA, Solomon H, Holman MJ, Gibbs JF, Watemberg I, Goldstein RM, Husberg BS. The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors. Transplantation. 1992 Feb; 53(2):383-6.
    View PubMed
  132. Mor E, Solomon H, Gibbs JF, Holman MJ, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB. Acute cellular rejection following liver transplantation: clinical pathologic features and effect on outcome. Semin Liver Dis. 1992 Feb; 12(1):28-40.
    View PubMed
  133. Gonwa TA, Husberg BS, Klintmalm GB, Mai ML, Goldstein RM, Capehart JE, Miller AH, Johnston SB, Alivizatos PA. Simultaneous heart and kidney transplantation: a report of three cases and review of the literature. J Heart Lung Transplant. 1992 Jan-Feb; 11(1 Pt 1):152-5.
    View PubMed
  134. Mora NP, Husberg BS, Gonwa TA, Goldstein R, Klintmalm GB. The impact of the different severe infections on the outcome of liver transplantation. A study of 150 patients. Transpl Int. 1992; 5:s209-s210.
    View PubMed
  135. Brinker K, Gonwa TA. Kidney transplantation in Dallas: 1964-1991. Dallas County Medical Society Journal. 1991 Dec; 539-41.
  136. Mora NP, Klintmalm GB, Cofer JB, Solomon H, Goldstein RM, Gonwa TA, Husberg BS. Results after liver retransplantation in a group of 50 regrafted patients: two different concepts of elective versus emergency retransplantation. Transpl Int. 1991 Dec; 4(4):231-4.
    View PubMed
  137. Gonwa TA, Morris CA, Mai ML, Husberg BS, Goldstein RM, Klintmalm GB. Race and liver transplantation. Arch Surg. 1991 Sep; 126(9):1141-3.
    View PubMed
  138. Brown M, Gunning T, Roberts C, Swygert T, Klintmalm G, Ramsay MA, Gonwa TA. Biochemical markers of renal perfusion are preserved during liver transplantation with venovenous bypass. Transplant Proc. 1991 Jun; 23(3):1980-1.
    View PubMed
  139. Goldstein RM, Klintmalm GK, Husberg BS, Gonwa TA, Polter D. Liver transplantation: a review of the first 200 patients. Transplant Proc. 1991 Apr; 23(2):1780-1.
    View PubMed
  140. Cofer JB, Morris CA, Sutker WL, Husberg BS, Goldstein RM, Gonwa TA, Klintmalm GB. A randomized double-blind study of the effect of prophylactic immune globulin on the incidence and severity of CMV infection in the liver transplant recipient. Transplant Proc. 1991 Feb; 23(1 Pt 2):1525-7.
    View PubMed
  141. Mora NP, Cofer JB, Solomon H, Goldstein RM, Gonwa TA, Husberg BS, Klintmalm GB. Analysis of severe infections (INF) after 180 consecutive liver transplants: the impact of amphotericin B prophylaxis for reducing the incidence and severity of fungal infections. Transplant Proc. 1991 Feb; 23(1 Pt 2):1528-30.
    View PubMed
  142. Husberg BS, Goldstein RM, Klintmalm GB, Gonwa T, Ramsay M, Cofer J, Solomon H, Watemberg I. A totally failing liver may be more harmful than no liver at all: three cases of total hepatic devascularization in preparation for emergency liver transplantation. Transplant Proc. 1991 Feb; 23(1 Pt 2):1533-5.
    View PubMed
  143. Goldstein R, Clark P, Klintmalm G, Husberg B, Gonwa T, Stone M. Prevention of recurrent thrombosis following liver transplantation for Budd-Chiari syndrome associated with myeloproliferative disorders: treatment with hydroxyurea and aspirin. Transplant Proc. 1991 Feb; 23(1 Pt 2):1559-60.
    View PubMed
  144. Turrion VS, Mora NP, Cofer JB, Solomon H, Morris CA, Gonwa TA, Goldstein RM, Husberg BS, Klintmalm GB. Retrospective evaluation of liver transplantation for cirrhosis: a comparative study of 100 patients with or without previous porto-systemic shunt. Transplant Proc. 1991 Feb; 23(1 Pt 2):1570-1.
    View PubMed
  145. Gonwa TA, Morris CA, Goldstein RM, Husberg BS, Klintmalm GB. Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome--experience in 300 patients. Transplantation. 1991 Feb; 51(2):428-30.
    View PubMed
  146. Gunning TC, Brown MR, Swygert TH, Goldstein R, Husberg BS, Klintmalm GB, DiBona G, Paulsen AW, Ramsay MA, Gonwa TA. Perioperative renal function in patients undergoing orthotopic liver transplantation. A randomized trial of the effects of verapamil. Transplantation. 1991 Feb; 51(2):422-7.
    View PubMed
  147. Mora NP, Klintmalm GB, Cofer JB, Poplawski SS, Goldstein RM, Gonwa TA, Husberg BS. Results after liver retransplantation (RETx): a comparative study between "elective" vs "nonelective" RETx. Transplant Proc. 1990 Aug; 22(4):1509-11.
    View PubMed
  148. Mora NP, Klintmalm GB, Poplawski SS, Cofer JB, Husberg BS, Gonwa TA, Goldstein RM. Recurrence of hepatitis B after liver transplantation: does hepatitis-B-immunoglobulin modify the recurrent disease? Transplant Proc. 1990 Aug; 22(4):1549-50.
    View PubMed
  149. Brinker KR, Dickerman RM, Gonwa TA, Hull AR, Langley JW, Long DL, Nesser DA, Trevino G, Velez RL, Vergne-Marini PJ. A randomized trial comparing double-drug and triple-drug therapy in primary cadaveric renal transplants. Transplantation. 1990 Jul; 50(1):43-9.
    View PubMed
  150. Cofer JB, Klintmalm GB, Howard TK, Morris CV, Husberg BS, Goldstein RM, Gonwa TA. A comparison of UW with Eurocollins preservation solution in liver transplantation. Transplantation. 1990 Jun; 49(6):1088-93.
    View PubMed
  151. Sayage L, Gunby R, Gonwa T, Husberg B, Goldstein R, Klintmalm G. Cytomegalovirus endometritis after liver transplantation. Transplantation. 1990 Apr; 49(4):815-7.
    View PubMed
  152. Howard TK, Klintmalm GB, Cofer JB, Husberg BS, Goldstein RM, Gonwa TA. The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation. 1990 Jan; 49(1):103-7.
    View PubMed
  153. Goldstein RM, Solomon H, Holman MJ, Gibbs JF, Mor E, Morris CA, Husberg BS, Gonwa TA, Klintmalm GB. Liver transplantation, 1990: a Dallas perspective. Clin Transpl. 1990; 123-33.
  154. Klintmalm GB, Nery JR, Husberg BS, Gonwa TA, Tillery GW. Rejection in liver transplantation. Hepatology. 1989 Dec; 10(6):978-85.
    View PubMed
  155. Sayage LH, Gonwa TA, Goldstein RM, Husberg BS, Klintmalm GB. Cytomegalovirus infection in orthotopic liver transplantation. Transpl Int. 1989 Aug; 2(2):96-101.
    View PubMed
  156. Poplawski S, Gonwa T, Goldstein R, Husberg B, Klintmalm G. Long term nephrotoxicity in liver transplantation. Transplant Proc. 1989 Feb; 21(1 Pt 2):2469-71.
    View PubMed
  157. Edwards LC, Nikaein A, Bryan C, Gonwa T, Klintmalm G, Husberg B, White M, Stone MJ. The predictive role of immunologic tests in liver transplant rejection. Transplant Proc. 1989 Feb; 21(1 Pt 2):2282-3.
    View PubMed
  158. Zachariah NY, Nikaein A, Gonwa T, Alivazatos P, Klintmalm G, Husberg B. Neopterin: a biochemical marker in the process of organ transplantation. Transplant Proc. 1989 Feb; 21(1 Pt 2):2294-6.
    View PubMed
  159. Gonwa TA, Poplawski S, Paulsen W, Brajtbord D, Goldstein R, Husberg B, Klintmalm G. Hepatorenal syndrome and orthotopic liver transplantation. Transplant Proc. 1989 Feb; 21(1 Pt 2):2419-20.
    View PubMed
  160. Gonwa TA, Poplawski S, Paulsen W, Brajtbord D, Goldstein R, Husberg B, Klintmalm GB. Pathogenesis and outcome of hepatorenal syndrome in patients undergoing orthotopic liver transplant. Transplantation. 1989 Feb; 47(2):395-7.
    View PubMed
  161. Poplawski SC, Gonwa TA, Goldstein RM, Husberg B, Klintmalm GBG. Cyclosporine induced renal dysfunction following orthotopic liver transplantation. Clin Transplant. 1989; 3:94-100.
  162. Sayage LH, Husberg BS, Klintmalm GBG, Goldstein RM, Gonwa TA. Vascular complications in adult liver transplant patients: the value of post operative doppler ultrasound screening and the surgical management of hepatic arterial thrombosis. Clin Transplant. 1989; 3:344-8.
  163. Gonwa TA, Nery JR, Husberg BS, Klintmalm GB. Simultaneous liver and renal transplantation in man. Transplantation. 1988 Nov; 46(5):690-3.
    View PubMed
  164. Nery J, Klintmalm G, Olson L, Neely S, Rippert L, Gonwa T, Husberg B. Incidence and outcome of acute rejection in liver transplantation. Transplant Proc. 1988 Jun; 20(3 Suppl 3):375-7.
    View PubMed
  165. Gonwa TA, Capehart JE, Pilcher JW, Alivizatos PA. Cytomegalovirus myocarditis as a cause for cardiac dysfunction in a heart transplant recipient. Transplantation. 1988; 47:177-81.
  166. Poplawski SC, Gonwa TA, Goldstein RM, Husberg B, Klintmalm GBG. Allergic interstitial nephritis secondary to OKT-3 therapy in a renal transplant recipient. Clin Transplant. 1988; 2:341-3.
  167. Gonwa TA, Klintmalm GB, Husberg BS, Olson L, Nery J, Roden J. Liver transplantation in patients with preexisting acute and chronic renal failure. Transplant Proc. 1988; 20:561-3.
  168. Goldstein RM, Klintmalm GBG, Olson LM, Husberg BS, Nery JR, Gonwa TA, Polter DE. Decreased mortality associated with orthotopic liver transplantation. Transplant Proc. 1988; 20:505-7.
    View PubMed
  169. Gonwa TA, Poplawski SC, Husberg BS, Nery JR, Klintmalm GB. Cyclosporine nephrotoxicity in orthotopic liver transplantation. Transplant Proc. 1988; 20:561-3.
  170. Gonwa TA, Velez R, Atkins C, Brinker K, Nesser D, Dickerman R, Long D, Hull A, Vergne P. Metabolic consequences of cyclosporine at azathioprine conversion in renal transplantation. Clin Transplant. 1988; 2:91-6.
  171. Gonwa TA, Nghiem DD, Corry RJ. Cyclosporine to azathioprine conversion in cadaveric renal transplants. Transplant Proc. 1987 Feb; 19(1 Pt 3):2018-20.
    View PubMed
  172. Corry RJ, Nghiem DD, Schanbacher B, Gonwa TA. Critical analysis of mortality and graft loss following simultaneous renal-pancreatic duodenal transplantation. Transplant Proc. 1987 Feb; 19(1 Pt 3):2305-6.
    View PubMed
  173. Nghiem DD, Gonwa TA, Corry RJ. Metabolic monitoring in renal-pancreatic transplants with urinary pancreatic exocrine diversion. Transplant Proc. 1987 Feb; 19(1 Pt 3):2350-1.
    View PubMed
  174. Gonwa TA, Nghiem DD, Schulak JA, Corry RJ. Results of conversion from cyclosporine to azathioprine in cadaveric renal transplantation. Transplantation. 1987 Feb; 43(2):225-8.
    View PubMed
  175. Nghiem DD, Gonwa TA, Corry RJ. Metabolic effects of urinary diversion of exocrine secretions in pancreatic transplantation. Transplantation. 1987 Jan; 43(1):70-3.
    View PubMed
  176. Vergne-Marini P, Dickerman R, Nesser D, Trevino G, Velez R, Parker T, Langley J, Brinker K, Hull A, Gonwa T, Long D. A historical perspective of transplantation and review of the results at Methodist Medical Center. Bulletin of the Medical Staff of Methodist Hospitals of Dallas. 1987; 13:5-12.
  177. Gonwa TA, Goeken NE, Schulak JA, Nghiem DD, Corry RJ. Changes in anti-HLA antibody levels associated with immunosuppression. Transplant Proc. 1986 Dec; 18(6):1865-7.
    View PubMed
  178. Gonwa TA. Hybrid Ia antigens in man. Detection with cytotoxic T cell clones. Transplantation. 1986 Oct; 42(4):423-9.
    View PubMed
  179. Gonwa TA, Frost JP, Karr RW. All human monocytes have the capability of expressing HLA-DQ and HLA-DP molecules upon stimulation with interferon-gamma. J Immunol. 1986 Jul 15; 137(2):519-24.
    View PubMed
  180. Gonwa TA, Nghiem DD, Schulak JA, Corry RJ. Erythromycin and cyclosporine. Transplantation. 1986 Jun; 41(6):797-9.
    View PubMed
  181. Corry RJ, Nghiem DD, Schulak JA, Beutel WD, Gonwa TA. Surgical treatment of diabetic nephropathy with simultaneous pancreatic duodenal and renal transplantation. Surgery, Gynecology & Obstetrics. 1986 Jun; 162(6):547-55.
    View PubMed
  182. Chen E, Karr RW, Frost JP, Gonwa TA, Ginder GD. Gamma interferon and 5-azacytidine cause transcriptional elevation of class I major histocompatibility complex gene expression in K562 leukemia cells in the absence of differentiation. Mol Cell Biol. 1986 May; 6(5):1698-705.
    View PubMed
  183. Gonwa TA, Nghiem DD, Schulak JA, Corry RJ. Cyclosporine use in early graft dysfunction. Transplant Proc. 1986 Apr; 18(2 Suppl 1):104-12.
    View PubMed
  184. Gonwa TA, Goeken NE, Schulak JA, Nghiem DD, Corry RJ. Failure of cyclosporine to prevent in vivo T cell priming in man. Studies in allogeneic spleen transplantation. Transplantation. 1985 Sep; 40(3):299-304.
    View PubMed
  185. Goeken NE, Gonwa TA, Schulak JA, Nghiem DD, Hunsicker L, Corry R. The adverse effect of cyclosporine introduction on organ sharing and HLA matching. Transplant Proc. 1985; 17:2184-6.
  186. Gonwa TA, Stobo JD. Differential expression of Ia molecules by human monocytes. J Clin Invest. 1984 Sep; 74(3):859-66.
    View PubMed
  187. Gonwa TA, Westrick MA, Macher BA. Inhibition of mitogen- and antigen-induced lymphocyte activation by human leukemia cell gangliosides. Cancer Res. 1984 Aug; 44(8):3467-70.
    View PubMed
  188. Peterlin BM, Gonwa TA, Stobo JD. Expression of HLA-DR by a human monocyte cell line is under transcriptional control. Journal of Molecular & Cellular Immunology. 1984; 1(3):191-200.
    View PubMed
  189. Biava CG, Gonwa TA, Naughton JL, Hopper J Jr. Crescentic glomerulonephritis associated with nonrenal malignancies. Am J Nephrol. 1984; 4(4):208-14.
    View PubMed
  190. Gonwa TA, Picker LJ, Raff HV, Goyert SM, Silver J, Stobo JD. Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR. J Immunol. 1983 Feb; 130(2):706-11.
    View PubMed
  191. Gonwa TA, Peterlin BM, Stobo JD. Human-Ir genes: structure and function. Adv Immunol. 1983; 34:71-96.
    View PubMed
  192. Gonwa TA, Hamilton RW, Buckalew VM Jr. Chronic renal failure and end-stage renal disease in northwest North Carolina. Importance of analgesic-associated nephropathy. Arch Intern Med. 1981 Mar; 141(4):462-5.
    View PubMed
  193. Gonwa TA, Corbett WT, Schey HM, Buckalew VM Jr. Analgesic-associated nephropathy and transitional cell carcinoma of the urinary tract. Ann Intern Med. 1980 Aug; 93(2):249-52.
    View PubMed
  194. Bass DA, Gonwa TA, Szejda P, Cousart MS, DeChatelet LR, McCall CE. Eosinopenia of acute infection: Production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest. 1980 Jun; 65(6):1265-71.
    View PubMed
  195. Gonwa TA, Beard GA, Buckalew VM Jr, Meredith JH, Heise ER. Comparison of antihuman T-cell globulin (ATG) produced against thymocytes and nylon nonadherent tonsillar lymphocytes. Proceedings of the Clinical Dialysis & Transplant Forum. 1979; 9:155-9.
    View PubMed